Novo Nordisk A/S Sued In U.S. Over Generic Prandin

Published: Jan 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Denmark's Novo Nordisk has been sued by a group of healthcare purchasing companies in the United States for allegedly wrongfully keeping generic copies of its Prandin diabetes drug off the market. A spokesman for Novo said on Tuesday the company aimed to get the case dismissed, but had no further comment. In 2005 Caraco Pharmaceutical Laboratories, a subsidiary of Indian drug maker Sun Pharmaceutical Industries, applied to get a generic version of Prandin approved by 2009, when Novo's patent on the drug would expire.

Help employers find you! Check out all the jobs and post your resume.

Back to news